Apitope

Biotechnology Research • Diepenbeek, Flemish Region, Belgium • 1-10 Employees

Company overview

Headquarters	Diepenbeek, Flemish Region, Belgium
Website	apitope.com
NAICS	541714
SIC	283
Founded	2002
Employees	1-10
Socials

Key Contacts at Apitope

David Wraith

Founder, Director And Cso

Lotta Jansson

Research Director

Apitope Email Formats

Apitope uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@apitope.com), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@apitope.com	100%

About Apitope

Apitope is a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapeutics targeting the immunological basis of autoimmune diseases. We use our novel, proprietary discovery platform to select and develop highly specific peptide-based therapies, known as “apitopes®”, which restore the natural balance (immune tolerance) of the immune system. This mechanism of action avoids global immune suppression and has the broad potential to treat a wide variety of autoimmune diseases. Apitope’s lead product candidate ATX-MS-1467 is in clinical development for treating multiple sclerosis (“MS”). ATX-MS-1467 is the first potential therapeutic for MS that combines high efficacy with an excellent, and thereby differentiating, safety profile. Apitope’s other lead product candidate ATX-GD-59 demonstrates potential to be the first disease-modifying treatment for Graves' disease and the first potential innovative treatment for the disease in more than 60 years. In addition, Apitope has developed a robust pipeline with several innovative, potential first-in-class product candidates advancing towards clinical development for the treatment of, amongst other indications, uveitis, factor VIII inhibitors, myocarditis, and rheumatoid arthritis. Founded in 2002, Apitope has an experienced leadership team with a strong track record in the pharmaceutical industry and scientific community.

Apitope revenue & valuation

Annual revenue	$10,000,000
Revenue per employee	$5,000,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$32,000,000
Total funding	$13,500,000

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Director

Employees by Department

Apitope has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Apitope's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2015-10-29	5	$13,500,000

Funding Insights

$13,500,000

Total funding amount

$13,500,000

Most recent funding amount

Number of funding rounds

Apitope Tech Stack

Discover the technologies and tools that power Apitope's digital infrastructure, from frameworks to analytics platforms.

Flask

Web frameworks

Python

Programming languages

Microsoft 365

Frequently asked questions

Apitope is located in Diepenbeek, Flemish Region, BE.

Apitope was founded in 2002, making it 24 years old. The company has established itself as a significant player in its industry over this time.

Apitope has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Apitope has raised a total of $13,500,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Apitope

David Wraith

Founder, Director And Cso

Lotta Jansson

Research Director

4.8

40,000 users